Medical News

[ Two-Thirds Of Men Reported Erection Problems, Often Linked To Lack Of Sex Drive, In Email Sexual Advice Study ]

Two-Thirds Of Men Reported Erection Problems, Often Linked To Lack Of Sex Drive, In Email Sexual Advice Study

More than two-thirds of men who contacted an email advice service run by a leading sexual advice charity had erection problems, which were frequently linked to loss of sex drive, according to research in the October issue of IJCP, the International Journal of Clinical Practice. The study by UK researchers also found that a large number of men from the Middle East and Indian subcontinent sought email advice on problems with premature ejaculation and masturbation. Previous research has suggested that these issues are often related to arranged marriages. People can contact the UK-based Sexual Advice Association by telephone or email and talk to a chartered psychologist. More detailed advice is available from a multi-disciplinary medical team that includes a family doctor with a special interest in men's health, a cardiologist, urologist, psychiatrist, gynaecologist and sexual health clinical nurse practitioner.

Predicting Sexual Function After Prostate Cancer Treatment Has Improved

A study published in the Sept. 21 issue of the Journal of the American Medical Association by a Beth Israel Deaconess Medical Center research team, suggests more open discussion between doctor and patient will assist in improving quality of life for prostate cancer survivors. The report shows survival rates for early stage prostate cancer sufferers are increasing, making quality of life issues a more important part of treatment, with the main focus being sexual function in previously potent men. Doctors are more able to predict the outcome of a man's sexual function post treatment and this should facilitate more patient / doctor discussion. Lead researcher, Martin G. Sanda, MD, Director of the Prostate Center at Beth Israel Deaconess Medical Center and Associate Professor of Urology at Harvard Medical School clarifies that : "It's a daunting situation for any man to face cancer .

VIVUS Announces FDA Acceptance Of Avanafil New Drug Application For Treatment Of Erectile Dysfunction

VIVUS, Inc. (NASDAQ: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its investigational drug candidate, avanafil, for the treatment of erectile dysfunction (ED). The target date for the FDA to complete its review of the avanafil NDA is April 29, 2012. In previously announced results from the pivotal phase 3 trials, patients treated with avanafil achieved significant improvement in erectile function compared to placebo. The avanafil development program included over 1, 350 patients and avanafil was shown to be well tolerated and effective in treating patients with general ED and diabetics with ED. The long-term safety study also confirmed the results observed in the phase 3 studies. "We are pleased with FDA's acceptance of our NDA.

Erectile Dysfunction And Inability To Orgasm

For men with erectile dysfunction (ED), 65 percent are unable to have an orgasm and 58 percent have problems with ejaculation, according to new research led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study followed 12, 130 men with mild to severe ED and is the largest-ever analysis of orgasmic and ejaculatory dysfunction. Results are published in the British Journal of Urology International. Approximately 30 million American men, or half of all men aged 40 to 70, have trouble achieving or sustaining an erection. "While medications like Viagra or Cialis have been successful in helping many of these men, our research suggests there are other common sexual issues that remain largely unaddressed, " says Dr. Darius Paduch, the study's lead author;

What Is Levitra? What Is Vardenafil?

Vardenafil, known under the brand name Levitra is a prescription medication for male erectile dysfunction treatment. It belongs to a class of drugs called PDE5 inhibitors. Levitra increases blood flow to the penis, which helps gain and sustain an erection during sex. Levitra's active ingredient works on the chain of reactions within the penis during arousal, when the corpus cavernosa (two large chambers) in the male's penis fills with blood, resulting in an erection. A penile erection happens when the penis fills with blood. This occurs when the blood vessels that supply the penis with blood expand (dilate), and the vessels that take blood away from the penis contract, resulting in an accumulation of blood in the penis. When a male is sexually aroused, nitric oxide is released into his penis.

Fast: [10]

Medical News © Nanda
Designer Damodar